Studies from our laboratory confirmed that, in pancreatic cancer cells, intracellular cAMP upregulates MRP4 through an Epac2/Rap1-mediated mechanism, whereas extracellular cAMP inhibits MRP4 promoter activity by a MEK/ERK-mediated pathway26. Here, MAP2K7 is linked to familial pancreatic carcinoma.